Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Incentivizing Biotech Growth; States and Regions Look to Stand Out from the Crowd

map_sm_0_0

The United States’ prolonged economic woes have drastically impacted state budgets, causing across-the-board program cuts and reassessment of priorities. The bioscience industry was not immune to the crisis, but did begin to rebound much faster than many other industries. Because the biosciences remain a source of high-wage, high-skill jobs, almost every state in the country is actively engaged in building fundamental industry infrastructure. State-sponsored programs to encourage investment and help bioscience companies leverage existing resources Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Policies that Benefit Start-Ups Grow the Bio-Economy

lab

The United States remains the land of entrepreneurialism despite our lingering economic troubles. To maintain our nation’s global leadership and drive job growth, we must continue to create policies that encourage and reward innovation in growth industries — including biotechnology. Jeffrey Bussgang, a general partner at the venture capital firm Flybridge Capital Partners contributed an interesting piece to Fortune/CNN Money in which he points out that start-up companies – not small businesses – are the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

Doggonn It! This Kitty May Be Researchers’ New Best Friend

Cat

The glow-in-the-dark cat is out of the bag. Researchers at the Mayo Clinic in Rochester, Minnesota have genetically modified domestic cats to resist the feline form of AIDS. As reported in the journal Nature Methods, this new achievement is a milestone in the ongoing quest to protect humans from the virus. And yes, these kitties glow in the dark. A green fluorescent protein was added to a gene from rhesus macaque monkeys that is known Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Registration Now Open for California Healthcare Institute’s Annual Meeting

chi-logo-small

Register Now for CHI Annual Meeting, Nov. 3, in San Francisco and Save Register now for CHI’s 2011 Annual Meeting, focused on the relationship between biomedical innovation and public policy, and receive early-bird savings to this signature event. The annual meeting, “Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model,” takes place Thursday, Nov. 3, at San Francisco’s Julia Morgan Ballroom. The event will bring together hundreds of leading executives from biotechnology, medical device and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

Q&A on Emmy Award Winning Biotech Education Campaign

Matt Gardner

While the biotechnology industry was born in Northern California over thirty years ago, companies falling under its broad umbrella can now be found in every corner of the world. From humble beginnings, its impact can now be seen in everything from consumer goods to cancer drugs. None-the-less, Northern California remains the center of the industry’s growing orbit. Many of the world’s greatest research institutions and biotech companies were born here and remain headquartered here. To Read More >

Business and Investments  |  Leave a comment  |  Email This Post